Substrate Specificities and Identification of Putative Substrates of ATM Kinase Family Members*
暂无分享,去创建一个
[1] C. Wang,et al. Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response. , 1999, Science.
[2] Lei Li,et al. hRAD17, a structural homolog of the Schizosaccharomyces pombe RAD17 cell cycle checkpoint gene, stimulates p53 accumulation , 1999, Oncogene.
[3] M. Hill. Minerva should not review retrospective audits , 1999, BMJ.
[4] M. Swift,et al. Link between breast cancer and ATM gene is strong , 1999, BMJ.
[5] J. Hoeijmakers,et al. Human and mouse homologs of the Schizosaccharomyces pombe rad17+ cell cycle checkpoint control gene. , 1998, Genomics.
[6] C. Canman,et al. The role of ATM in DNA damage responses and cancer , 1998, Oncogene.
[7] P. Leder,et al. Loss of atm radiosensitizes multiple p53 null tissues. , 1998, Cancer research.
[8] P. Jeggo,et al. Splitting the ATM: distinct repair and checkpoint defects in ataxia-telangiectasia. , 1998, Trends in genetics : TIG.
[9] X. Shen,et al. The mammalian Rad24 homologous to yeast Saccharomyces cerevisiae Rad24 and Schizosaccharomyces pombe Rad17 is involved in DNA damage checkpoint. , 1998, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[10] F. Alt,et al. Late embryonic lethality and impaired V (D)J recombination in mice lacking DNA ligase IV , 1998, Nature.
[11] Y Taya,et al. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. , 1998, Science.
[12] S. Jackson,et al. DNA repair: The Nijmegen breakage syndrome protein , 1998, Current Biology.
[13] M. Lavin. Role of the ataxia-telangiectasia gene (ATM) in breast cancer , 1998, BMJ.
[14] S. Takashima,et al. Expression of the ataxia-telangiectasia gene (ATM) product in human cerebellar neurons during development , 1998, Neuroscience Letters.
[15] R. Darnell,et al. ATM binds to β-adaptin in cytoplasmic vesicles , 1998 .
[16] M. Cole,et al. The Novel ATM-Related Protein TRRAP Is an Essential Cofactor for the c-Myc and E2F Oncoproteins , 1998, Cell.
[17] S. Jackson,et al. The DNA-dependent protein kinase , 1999 .
[18] Y Taya,et al. DNA damage induces phosphorylation of the amino terminus of p53. , 1997, Genes & development.
[19] Y. Houvras,et al. Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiPl , 1997, Nature.
[20] M. Gatei,et al. Cellular localisation of the ataxia-telangiectasia (ATM) gene product and discrimination between mutated and normal forms , 1997, Oncogene.
[21] Y. Shiloh,et al. Fragments of ATM which have dominant-negative or complementing activity , 1997, Molecular and cellular biology.
[22] F. Collins,et al. The ataxia-telangiectasia gene product, a constitutively expressed nuclear protein that is not up-regulated following genome damage. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[23] A. Carr. Control of cell cycle arrest by the Mec1sc/Rad3sp DNA structure checkpoint pathway. , 1997, Current opinion in genetics & development.
[24] Yonghong Xiao,et al. Association of BRCA1 with Rad51 in Mitotic and Meiotic Cells , 1997, Cell.
[25] M. Kastan,et al. p53 and ATM: cell cycle, cell death, and cancer. , 1997, Advances in cancer research.
[26] Y. Shiloh,et al. The genetic defect in ataxia-telangiectasia. , 1997, Annual review of immunology.
[27] Y. Shiloh,et al. Ataxia-telangiectasia and the Nijmegen breakage syndrome: related disorders but genes apart. , 1997, Annual review of genetics.
[28] Gang Chen,et al. The Product of the ATM Gene Is a 370-kDa Nuclear Phosphoprotein* , 1996, The Journal of Biological Chemistry.
[29] T. Stankovic,et al. Analysis of the ATM protein in wild-type and ataxia telangiectasia cells. , 1996, Oncogene.
[30] L. Pinna,et al. How do protein kinases recognize their substrates? , 1996, Biochimica et biophysica acta.
[31] S. Schreiber,et al. PIK-Related Kinases: DNA Repair, Recombination, and Cell Cycle Checkpoints , 1995, Science.
[32] T. Hunter,et al. When is a lipid kinase not a lipid kinase? When it is a protein kinase , 1995, Cell.
[33] V. Zakian. ATM-related genes: What do they tell us about functions of the human gene? , 1995, Cell.
[34] K. Khanna,et al. Nature of G1/S cell cycle checkpoint defect in ataxia-telangiectasia. , 1995, Oncogene.
[35] M. Skolnick,et al. BRCA1 mutations in primary breast and ovarian carcinomas. , 1994, Science.
[36] Steven E. Bayer,et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. , 1994, Science.
[37] A. Fornace,et al. The p53-dependent G1 cell cycle checkpoint pathway and ataxia-telangiectasia. , 1994, Cancer research.
[38] S. Jackson,et al. The DNA-dependent protein kinase: Requirement for DNA ends and association with Ku antigen , 1993, Cell.
[39] B. Vogelstein,et al. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia , 1992, Cell.
[40] K. Sakaguchi,et al. Human DNA-activated protein kinase phosphorylates serines 15 and 37 in the amino-terminal transactivation domain of human p53 , 1992, Molecular and cellular biology.
[41] W. Herr,et al. Ethidium bromide provides a simple tool for identifying genuine DNA-independent protein associations. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[42] D Morrell,et al. Incidence of cancer in 161 families affected by ataxia-telangiectasia. , 1991, The New England journal of medicine.
[43] M. Swift,et al. Breast and other cancers in families with ataxia-telangiectasia. , 1987, The New England journal of medicine.
[44] A. Nordheim,et al. DNA intercalators induce specific release of HMG 14, HMG 17 and other DNA‐binding proteins from chicken erythrocyte chromatin. , 1985, The EMBO journal.